375 related articles for article (PubMed ID: 21633513)
41. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.
Chavchich M; Gerena L; Peters J; Chen N; Cheng Q; Kyle DE
Antimicrob Agents Chemother; 2010 Jun; 54(6):2455-64. PubMed ID: 20350946
[TBL] [Abstract][Full Text] [Related]
42. Mutation analysis in pfmdr1 and pfmrp1 as potential candidate genes for artemisinin resistance in Plasmodium falciparum clinical isolates 4years after implementation of artemisinin combination therapy in Iran.
Pirahmadi S; Zakeri S; Afsharpad M; Djadid ND
Infect Genet Evol; 2013 Mar; 14():327-34. PubMed ID: 23287027
[TBL] [Abstract][Full Text] [Related]
43. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
[TBL] [Abstract][Full Text] [Related]
44. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.
Ng CL; Siciliano G; Lee MC; de Almeida MJ; Corey VC; Bopp SE; Bertuccini L; Wittlin S; Kasdin RG; Le Bihan A; Clozel M; Winzeler EA; Alano P; Fidock DA
Mol Microbiol; 2016 Aug; 101(3):381-93. PubMed ID: 27073104
[TBL] [Abstract][Full Text] [Related]
45. An online mapping database of molecular markers of drug resistance in Plasmodium falciparum: the ACT Partner Drug Molecular Surveyor.
Otienoburu SD; Suay I; Garcia S; Thomas NV; Srisutham S; Björkman A; Humphreys GS
Malar J; 2019 Jan; 18(1):12. PubMed ID: 30658642
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.
Alam MS; Ley B; Nima MK; Johora FT; Hossain ME; Thriemer K; Auburn S; Marfurt J; Price RN; Khan WA
Malar J; 2017 Aug; 16(1):335. PubMed ID: 28806961
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
[TBL] [Abstract][Full Text] [Related]
48. The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
Ochola-Oyier LI; Okombo J; Mwai L; Kiara SM; Pole L; Tetteh KK; Nzila A; Marsh K
Antimicrob Agents Chemother; 2015 Mar; 59(3):1770-5. PubMed ID: 25534732
[TBL] [Abstract][Full Text] [Related]
49. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
[TBL] [Abstract][Full Text] [Related]
50. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
51. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
[TBL] [Abstract][Full Text] [Related]
52. Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.
Veiga MI; Osório NS; Ferreira PE; Franzén O; Dahlstrom S; Lum JK; Nosten F; Gil JP
Antimicrob Agents Chemother; 2014 Dec; 58(12):7390-7. PubMed ID: 25267670
[TBL] [Abstract][Full Text] [Related]
53. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
[TBL] [Abstract][Full Text] [Related]
54. Molecular Surveillance and in vitro Drug Sensitivity Study of
Wang S; Xu S; Geng J; Si Y; Zhao H; Li X; Yang Q; Zeng W; Xiang Z; Chen X; Zhang Y; Li C; Kyaw MP; Cui L; Yang Z
Am J Trop Med Hyg; 2020 Sep; 103(3):1100-1106. PubMed ID: 32588794
[TBL] [Abstract][Full Text] [Related]
55. Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.
Sondo P; Derra K; Diallo Nakanabo S; Tarnagda Z; Kazienga A; Zampa O; Valéa I; Sorgho H; Owusu-Dabo E; Ouédraogo JB; Guiguemdé TR; Tinto H
PLoS One; 2016; 11(3):e0151565. PubMed ID: 27031231
[TBL] [Abstract][Full Text] [Related]
56. Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria.
Okore W; Ouma C; Okoth RO; Yeda R; Ingasia LO; Mwakio EW; Ochora DO; Wakoli DM; Amwoma JG; Chemwor GC; Juma JA; Okudo CO; Cheruiyot AC; Opot BH; Juma D; Egbo TE; Andagalu B; Roth A; Kamau E; Akala HM
PLoS One; 2024; 19(6):e0298585. PubMed ID: 38900782
[TBL] [Abstract][Full Text] [Related]
57. Distribution of pfmdr1 polymorphisms in Plasmodium falciparum isolated from Southern Thailand.
Mungthin M; Intanakom S; Suwandittakul N; Suida P; Amsakul S; Sitthichot N; Thammapalo S; Leelayoova S
Malar J; 2014 Mar; 13():117. PubMed ID: 24670242
[TBL] [Abstract][Full Text] [Related]
58. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
59. Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
Asua V; Vinden J; Conrad MD; Legac J; Kigozi SP; Kamya MR; Dorsey G; Nsobya SL; Rosenthal PJ
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559133
[TBL] [Abstract][Full Text] [Related]
60. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
